Salicylic Acid in Skincare: Brand Briefs, Samples & Claims

Quick answer

Before you ask a manufacturer for a salicylic acid sample, settle four things:

Destination markets. Each market sets its own conditions for using salicylic acid and its own rules on claims. List every market you plan to sell in.
Claim route. Decide whether you are making a cosmetic or a drug. In the United States, acne treatments are regulated as drugs, and a cleanser that is also an acne treatment is a combination drug-cosmetic that must meet both sets of requirements.
Format. A rinse-off face cleanser and a leave-on toner keep the acid on the skin for very different lengths of time, so they need different briefs, sample checks and claims. Market conditions are checked against the exact product type, so don’t assume one format allows more acid than the other.
User and use occasion. State who the product is for, how often it is used and what it is used with. Adult oily-skin users, teenagers, “sensitive skin” positioning and daily use each change the formula target, the warnings and the evidence you will need.

With these fixed, a formulator can propose an approach and you can judge samples against a written target. Without them, samples get judged on whether someone liked the feel, and claim problems turn up at artwork stage.

This guide is for brand owners, product developers and buyers planning a non-spray salicylic acid face cleanser or toner. It is not consumer advice on acne, and it gives no recommended concentration. The level is set for the final formula, product type, purpose and market, and is confirmed by the formulator and your regulatory reviewer.

Salicylic acid in a brief: name the ingredient precisely

Salicylic acid is what most cosmetic brands mean by “BHA”. The FDA’s consumer page on beta hydroxy acids describes it as the BHA most commonly used in cosmetics, while noting that chemically it is not a true beta hydroxy acid. In a brief, use the INCI name “Salicylic Acid”. Treat salicylates, sodium salicylate, willow bark extract and capryloyl salicylic acid (LHA) as separate options. Each must be named on the formula sheet and checked against its own market conditions.

This matters because “BHA” on a pack front can be read as “contains salicylic acid”. If the formula uses an alternative, the marketing and the ingredient list have to agree.

Brands often consider salicylic acid for appearance-led positions, such as the look of oily skin, visible pores or rough-looking texture. Whether a specific claim stays cosmetic depends on its wording and intended use in each destination market.

Decision 1: market and claim route

This section sets out the regulatory boundaries once. Later sections refer back to it.

United States: intended use decides the category

The FDA classifies products by intended use. Under the Federal Food, Drug, and Cosmetic Act, a cosmetic is intended for cleansing, beautifying, promoting attractiveness or altering the appearance. A drug is intended to diagnose, cure, mitigate, treat or prevent disease, or to affect the structure or any function of the body. The FDA states that acne treatments are regulated as drugs, and that a cleanser that is also an acne treatment is a combination drug-cosmetic (FDA: How can I tell if my product is a cosmetic, a drug, or both?).

The FDA also says intended use can be established by claims on labeling, in advertising, on the internet or in other promotional materials, and by consumer perception (FDA: Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)). The same page lists acne medications among the over-the-counter drug categories covered by FDA monographs. So keeping acne-treatment wording off the label is not enough if your website or listings use it.

This guide covers the cosmetic route. If you want an acne treatment claim in the US, scope the drug pathway with a regulatory specialist before briefing a cosmetic manufacturer.

The FDA’s older consumer page on beta hydroxy acids (FDA: Beta Hydroxy Acids) reports a tentative conclusion from a February 2000 meeting of the Cosmetic Ingredient Review (CIR) Expert Panel. The panel said salicylic acid related substances in cosmetics are “safe as used when formulated to avoid irritation and when formulated to avoid increased sun sensitivity”, and that directions should include daily sun protection where sun sensitivity would be expected. The page also gives consumer precautions: test on a small area, follow label directions, avoid use on infants and children, and use sun protection. It is dated consumer guidance, not a regulation and not a current safety finding. For a brief, it is a useful prompt for three checklist items: irritation, sun-protection directions and use by children.

European Union: product type, purpose and application method

In the EU, cosmetics are governed by Regulation (EC) No 1223/2009 (EUR-Lex), and salicylic acid is a restricted ingredient listed in its annexes. The conditions are set by named product type. The entry does not simply divide products into rinse-off and leave-on. A face cleanser washes off, but that does not put it in the same category as rinse-off hair products. Check the exact product type against the current consolidated text, not against a number on a product page, a supplier sheet or a competitor’s label. The annexes are amended over time.

Four conditions in the current consolidated text belong in an EU brief:

Purpose. Use of salicylic acid for purposes other than preserving the product is listed separately from its use as a preservative, and that purpose has to be apparent from the product’s presentation. The entry states that its levels include any use of salicylic acid in the product. If the formula uses it for more than one reason, ask the formulator how the total is accounted for.
Age. It is not to be used in preparations for children under 3, and a matching warning applies.
Inhalation. It is not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. This wording is part of the salicylic acid entry as replaced by Commission Regulation (EU) 2021/850.
Oral products. It is not to be used in oral products. This is less relevant to face care, but it shows that the entry is organised by product type and application method.

Spray formats are a separate question. This guide compares non-spray products only. If you are considering a mist or another sprayable format, check in each destination market whether that specific product could lead to inhalation exposure under the applicable condition. Not every spray is automatically prohibited, but the answer has to be on record before formulation starts.

The 2025 SCCS opinion: a scientific assessment, not a legal limit

The EU’s Scientific Committee on Consumer Safety (SCCS) adopted an opinion on salicylic acid and children’s exposure on 30 April 2025, reference SCCS/1675/25 (European Commission: SCCS opinion on salicylic acid, children’s exposure).

Scope. The opinion was requested by the European Commission and covers children aged 3 to 10, at the concentrations and uses in its terms of reference. It covers salicylic acid only, not other salicylates. It states that it does not apply to sprayable products that may lead to exposure of the user’s lungs by inhalation.
Findings within that scope. The SCCS considered aggregate exposure, meaning one child aged 3 to 10 using several product categories. On that basis it concluded that use at the assessed concentrations was not safe for several product types used by children. Where such a child uses salicylic acid in only one product category, it found the assessed use safe, except for body lotion. It also described lower levels it would consider safe for that age group, and it recorded that salicylic acid is an eye irritant with the potential to cause serious eye damage.
Status. An SCCS opinion informs the Commission. It does not change the legal conditions, which would need an amendment to the regulation. Do not cite it as “the EU limit”.

For a brand, the practical point is narrow. If an EU product is aimed at, marketed to or likely to be used by children aged 3 to 10, or if the same child could use several of your salicylic acid products across categories, follow how the Commission acts on the opinion and have your EU responsible person check the current legal text before the formula is set. The opinion did not assess teenagers. If teenagers are a target group in any market, check that market’s rules and evidence expectations separately.

Other markets

ASEAN markets, the UK, China, the Gulf states and other markets each set their own ingredient conditions and claim rules. A level or claim accepted in one market tells you nothing certain about another. Get a per-market answer on both acid use and claim wording before sampling. Our overview of cosmetic claims across the US, EU and China shows how the same wording can be treated differently across those three markets.

Decision 2: rinse-off cleanser or leave-on toner

This guide compares two possible product directions: a non-spray face cleanser that is rinsed off and a non-spray toner that stays on the skin. They call for different briefs and sample checks.

Swipe horizontally to view all columns →

Question	Rinse-off face cleanser	Leave-on toner (non-spray)
Contact time	Short. The product is rinsed off after washing.	Long. The product stays on skin until the next cleanse.
What the user notices	Foam, cleansing feel, after-feel (tight, clean, comfortable)	Tingle on application, residue, stickiness, how skin looks over days
Formulation questions to raise	How the acid stays dissolved in the surfactant base at the target pH; how a stripped after-feel is avoided	How the acid stays dissolved in a mostly water base; tingle; sun-protection directions; how it combines with any other acids
Typical cosmetic claim territory, subject to market review	Cleansing, removing excess oil, the look of pores, a fresh feel	Smoother-looking texture, the look of pores and oiliness
Market conditions	Check the conditions for this exact product type and purpose in each market.	Check the conditions for this exact product type and purpose in each market.
Packaging questions	Tube or pump: dispensing, foam, residue around the orifice	Screw-cap or pump bottle, or pad jar: contact with pack materials and seals, evaporation, pad use
Fits a range when	You want a familiar routine step with short contact time	You want the acid to be the centre of the routine and can support leave-on directions and evidence

Neither format is “gentle” or “strong” by default. Tolerability depends on the finished formula, its pH, the other ingredients, how often it is used and by whom. It has to be shown for that formula.

If the range will include both a cleanser and a toner, brief them together. Two salicylic acid products in one routine affect the usage directions and warnings. In the EU, they may also raise the aggregate-exposure question described above if children aged 3 to 10 could use them.

This guide does not compare salicylic acid with glycolic, lactic or polyhydroxy acids. If a toner combines salicylic acid with AHAs or PHAs, each acid needs its own market check, and the claims have to reflect what the finished combination is shown to do.

Discuss a cleanser or toner brief

Share your destination markets, intended claims, product format and packaging preferences. Confirm the formula, testing and supply details for your project before placing an order.

Send your brief →

Decision 3: write a brief a manufacturer can quote against

A useful brief shows what success looks like and records what is still open. This structure works for either format.

1. Product definition

Format: rinse-off face cleanser, leave-on toner, or both. State that the product is non-spray, or flag any spray format for a separate inhalation check.
Intended user: skin type, the age range you are designing for, and groups you do not target, such as children.
Use occasion: morning, evening or both; daily or a set number of times per week; alone or alongside other actives in your range.
Destination markets, in launch order.

2. Sensory and appearance target

Texture and appearance: for a cleanser, gel, cream or foam, clear or opaque; for a toner, water-thin or slightly viscous, clear or tinted.
After-feel: what the user should feel five minutes after use, for example comfortable, matte, not tight, no residue.
Fragrance: fragrance-free, or a defined scent with a limit on the fragrance-allergen declarations you will accept.
Reference products: one to three products, with what you like about each (“this foam density”, “this finish, not this smell”). A reference shows the target. It is not a request to copy a formula.

3. Packaging and channel

Pack type and material (tube, pump bottle, screw-cap bottle, pad jar), size, and whether you supply your own components.
Channel: e-commerce, retail, salon or clinic, cross-border marketplace. Channel affects temperature exposure in transit, shelf-life expectations and the documents a retailer will ask for.

4. Claim set

Split claims into three lists:

Intended claims, word for word, for label and marketing.
Possible claims you would use if the evidence supports them.
Excluded claims you will not use. For a cosmetic salicylic acid product this usually includes treating, preventing or curing acne; wording that implies treatment in your markets; “for sensitive skin” unless you will commission the evidence; and anything aimed at children.

Writing the excluded list early stops a designer, a listing or a creator brief drifting into drug or unsupported language later.

5. Items to ask the manufacturer to confirm in writing

Acid choice by INCI name: salicylic acid, or an alternative such as LHA, a salicylate or willow bark extract.
Proposed salicylic acid content and its purpose in the formula.
Proposed pH range for the finished product.
A formula code for every sample, so feedback and later tests refer to the same formula.
Which destination-market conditions the proposed use has been checked against, and by whom.
Which routine release checks are part of production, and which formal work (stability, packaging compatibility, preservative efficacy, safety assessment, claim support) would be scoped separately.

Don’t ask for “the safe concentration”. No single number applies across markets, product types, purposes and age groups. Ask for a proposed level for your product type and markets, with the basis for it.

Decision 4: evaluate samples against the brief

Sample rounds lose time when feedback is vague (“too strong”, “feels nice”) and nobody records which formula version was tested. A review should separate three things: what you can observe, what you can ask the manufacturer to change or explain, and what a sample review cannot prove.

The table below is an illustrative buyer example of a first sample round for a non-spray cleanser and a non-spray toner. It is not a real client, not a real test result and not a description of any GZ Cosmetics Lab formula.

Illustrative buyer example: first-round sample review (not real test data)

Swipe horizontally to view all columns →

Check	Cleanser sample (code C-01): what the buyer observes	Toner sample (code T-01): what the buyer observes	Revision questions to ask	Still needs formal evidence
Visible particles or precipitate	Clear at room temperature; a few specks after a night near a cold window	Clear in the bottle; faint white residue on the neck after a week of use	What are the specks or residue? Please investigate and send a revised sample with a new code.	Formal stability study on the final formula in the final pack, under conditions agreed for your markets and channel
pH and acid record	Label shows a formula code but no pH or acid content	Sheet gives a pH value and “salicylic acid: per market limit”	Please state the target pH range, the measured pH of this sample, the salicylic acid content and the formula version.	Finished-product specification with pH range and acid content, checked at release and through the stability study
Early appearance changes	No visible change after two weeks at room temperature	Slight colour shift after two weeks on a sunny shelf	What might explain the colour change, and what options would you test?	Formal stability work, including light exposure if relevant, on the final formula and pack
Packaging fit	Tube dispenses evenly; some product dries around the cap	Screw-cap bottle pours evenly; residue on the cap thread	Has this formula been checked in this exact tube or bottle? Any compatibility questions with the pack materials or seals?	Packaging compatibility testing with the chosen components over the stability period
Sensory	Foam lighter than the reference; after-feel clean but slightly tight	Brief tingle noted by the brand’s own team; tacky for a minute	Can the foam be denser and the after-feel less tight? What might cause the tingle and tackiness?	Team impressions are not tolerance evidence. Any tolerance or “suitable for” claim needs a properly designed study, scoped with a qualified provider
Claim evidence	Brand wants “helps reduce the look of excess oil” and “for oily skin”	Brand wants “smoother-looking skin” and “visibly refined pores”	Which of these could the formula be expected to support, and what evidence would you suggest, at what cost and timeline?	Substantiation matched to the exact wording and finished formula; safety assessment and label warnings for each market

Rules that make the table useful:

Record each sample version separately. Two products can sit side by side, but each column refers to one coded sample. When a revised formula arrives, add a new record under the new code and keep the old one.
Describe, then judge. Write what you saw (“white specks at the cap after one week”) before your verdict (“not acceptable”).
Keep team impressions in their place. Trying a sample tells you about sensory fit. It does not show tolerance, safety or claim support. Don’t run informal “patch tests” on staff or friends and treat them as evidence. Safety assessment and tolerance studies belong to qualified professionals.
Raise visible particles straight away. Record specks, crystals, cloudiness or residue with the sample code, date and storage conditions, and ask the formulator to investigate and resample. A clear sample at room temperature says little about shelf life. Formal stability work on the final formula and pack answers that.

Ordinary sample checks help you choose between options. Markets and retailers rely on formal work: stability, packaging compatibility, preservative efficacy, the safety assessment and claim support. Our guide to cosmetic efficacy testing covers how claim studies are scoped.

Decision 5: sign-off checklist before artwork

Check each claim and each product against every destination market, using the boundaries in Decision 1. Sign off only when each line has an answer on record.

Claim route: each claim is appearance, cleansing or feel wording, or the drug route has been chosen deliberately for that market.
Consistency: label, website, marketplace listings and promotional materials make the same claims.
User groups: any wording that implies a user group or use pattern (“for teens”, “for sensitive skin”, “daily”) has evidence or has been removed.
Acid use: the final acid use fits the current legal conditions for the exact product type, purpose and application method in each market.
Format: the product is confirmed non-spray, or a spray format has its own inhalation review on record.
Directions and warnings: sun-protection directions, eye-contact warnings and age warnings match each market’s requirements and your marketing.
Evidence: every claim on the label is matched to a named piece of evidence for the finished formula.

If a line fails in a market, change the claim, the formula or the route for that market and record the decision in the brief. No salicylic acid product should be described in advance as compliant in “all markets” or as having one “safe concentration” for every use.

From brief to inquiry

A complete brief turns directly into a quote request. Send it with these questions:

These are our destination markets and our intended, possible and excluded claims. Which acid (salicylic acid, LHA or another option) and which proposed level would you suggest for each market, and on what basis?
What pH range would you propose for this product type, and how will pH and acid content be recorded on each sample?
If a sample shows visible particles or precipitate, how will you investigate and confirm the fix?
Which of our packaging options has this type of formula been checked in, and what compatibility work would you recommend?
Which checks are part of routine release, and which formal stability, compatibility, safety and claim work would be scoped separately?
Will each sample carry a formula code that matches later documents?
What MOQ, sample lead time and production lead time would apply to this project once the formula and pack are settled?

Our catalog includes two related product directions. The Triple Acid Exfoliating Toner page lists salicylic acid as a BHA option alongside AHA and PHA options. The Oil Control Clarifying Cleanser page lists salicylic acid or LHA as alternative acids for a rinse-off step. Ask first whether either catalog direction is suitable for your project. If it is, confirm the proposed acid choice and level, target pH, testing scope, claim route and supply terms for each destination market; the checklist above still applies. When your brief and questions are ready, send them through our quote request form.

Summary

Fix markets, claim route, format and intended user before requesting samples.
Check acid use against the exact product type and purpose in each market, not against a rinse-off or leave-on label.
Keep this brief to non-spray formats, or give any spray its own inhalation review.
Code every sample, record pH and acid content, and keep observations separate from formal evidence.
Run the sign-off checklist before artwork.

Frequently Asked Questions

What concentration of salicylic acid should we ask for? Ask the manufacturer for a proposed level for your product type and markets, with the basis for it. Don’t name a number yourself or accept a single “safe” figure for all markets.

Can a salicylic acid cleanser say it is for acne? In the US, a cleanser intended to treat acne is a combination drug-cosmetic, so that claim means taking the drug route. Other markets draw this line in their own way. See Decision 1.

Does a rinse-off cleanser allow more salicylic acid than a toner? Don’t assume so. In the EU, conditions follow named product types, and a face cleanser is not in the rinse-off hair category. Check each product in each market.

Can we make a salicylic acid face mist? Treat it as a separate project. Check the inhalation conditions for that specific product in each market before briefing it.

Can a toner be called “gentle enough for daily use”? Only with evidence for that exact formula, usage pattern and user group. Salicylic acid toners are not gentle by default.

Our sample showed small crystals or specks. What should we do? Record what you saw with the sample code, date and storage conditions, ask the manufacturer to investigate and resample under a new code, and confirm the outcome through formal stability work before approval.

What documents should we ask for? Ask what formula code and ingredient information will come with each sample, what finished-product specification will exist for the approved formula, and which formal stability, compatibility, safety and claim documents are included or scoped separately.

Salicylic Acid in Skincare: A Brand's Guide to Formula Briefs, Samples and Claims